CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

BLISS GVS PHARMA LTD.

NSE : BLISSGVSBSE : 506197ISIN CODE : INE416D01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE366.1048.5 (+15.27 %)
PREV CLOSE () 317.60
OPEN PRICE () 321.90
BID PRICE (QTY) 365.90 (43)
OFFER PRICE (QTY) 366.50 (32)
VOLUME 817693
TODAY'S LOW / HIGH ()320.65 376.45
52 WK LOW / HIGH ()118.35 329.45
NSE365.8048.25 (+15.19 %)
PREV CLOSE() 317.55
OPEN PRICE () 321.00
BID PRICE (QTY) 365.80 (81)
OFFER PRICE (QTY) 365.95 (344)
VOLUME 10643372
TODAY'S LOW / HIGH() 320.85 376.50
52 WK LOW / HIGH ()118 329.2
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1984

Management Info :

Nandkumar chodankar - Chairman - Managing Director

Registered Office :

Address : 102, Hyde Park,Saki Vihar Road,Andheri (East) ,
Mumbai,
Maharashtra-400072

Phone : 022-42160000 / 28505387

Website : www.blissgvs.com

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Road,Vikhroli West,Mumbai
Listing : BSE, NSE
NEWS
21May Bliss GVS Pharma informs about disclo
Bliss GVS Pharma has informed that the exchange has received the disclos..
13May Grant Of Options Under Bliss GVS Phar
Please find enclosed herewith the outcome of Nomination and Remuneration..
08Apr Bliss GVS Pharma informs about credit
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Ob..
31Mar Bliss GVS Pharma informs about trading
Bliss GVS Pharma has informed that pursuant to the Securities Exchange B..
26Nov Bliss GVS Pharma’s arm incorporates wh
Bliss GVS Pharma’s wholly owned subsidiary -- Bliss GVS International, S..
Financials
in Millions
QTR Mar 26 ANNUAL 26
Net Profit324.22968.73
Gross Profit 441.54 1334.63
Operating Profit 534.491787.53
Net Sales 2115.377298.08
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Neuland Laboratories (BSE)
 17118.10 (2.24%)
M.Cap ( in Cr)
21955.79
Acutaas Chemicals (BSE)
 3030.45 (3.78%)
M.Cap ( in Cr)
24806.95
Hester Biosciences (BSE)
 1950.00 (3.43%)
M.Cap ( in Cr)
1618.13
Alivus Life Sciences (BSE)
 1109.95 (5.91%)
M.Cap ( in Cr)
13623.47
Wockhardt (BSE)
 1682.00 (2.60%)
M.Cap ( in Cr)
27379.93
Shareholding Pattern
NON-INSTITUTION 49.15%
PROMOTERS 35.36%
FI/BANKS/INSURANCE 4.33%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%
Mf Holding

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX76568.4579.49 (0.10%)
NIFTY24070.1538.45 (0.16%)
Dow Jones 50579.70294.04 (0.58%)
Nasdaq 26343.9750.87 (0.19%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI